Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates

被引：1
|
作者：
Vanhems, P [1 ]
Gaudet, R
Hirschel, B
Imrie, A
Conway, B
Rouleau, D
Vizzard, J
Perrin, L
Cooper, DA
Yerly, S
机构：
[1] Univ Lyon 1, INSERM U 271, Lab Epidemiol & Sante Publ, F-69365 Lyon, France
[2] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada
[3] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland
[4] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[5] Univ British Columbia, Dept Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada
来源：
AIDS | 2000年 / 14卷 / 08期
关键词：
D O I：
10.1097/00002030-200005260-00023
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1065 / 1067
页数：3
相关论文
共 50 条
  • [11] Prevalence of zidovudine-resistant HIV-1 among rapid progressors
    GarciaLerma, G
    Soriano, V
    GomezCano, M
    Bravo, R
    Mas, A
    delRomero, J
    Martin, R
    GonzalezLahoz, J
    AIDS, 1996, 10 (11) : 1292 - 1293
  • [12] TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1 THROUGH HETEROSEXUAL CONTACTS
    ANGARANO, G
    MONNO, L
    APPICE, A
    GIANNELLI, A
    ROMANELLI, C
    FICO, C
    PASTORE, G
    AIDS, 1994, 8 (07) : 1013 - 1014
  • [13] DETECTION OF ZIDOVUDINE-RESISTANT VARIANTS OF HIV-1 IN GENITAL FLUIDS
    WAINBERG, MA
    BEAULIEU, R
    TSOUKAS, C
    THOMAS, R
    AIDS, 1993, 7 (03) : 433 - 434
  • [14] MOTHER-TO-CHILD TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1
    SIEGRIST, CA
    YERLY, S
    KAISER, L
    WYLER, CA
    PERRIN, L
    LANCET, 1994, 344 (8939-4): : 1771 - 1772
  • [15] COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE COMPARED WITH ZIDOVUDINE ALONE IN HIV-1 INFECTION
    COLLIER, AC
    COOMBS, RW
    FISCHL, MA
    SKOLNIK, PR
    NORTHFELT, D
    BOUTIN, P
    HOOPER, CJ
    KAPLAN, LD
    VOLBERDING, PA
    DAVIS, LG
    HENRARD, DR
    WELLER, S
    COREY, L
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 786 - 793
  • [16] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1 (HIV-1) INHIBITORY INTERACTIONS BETWEEN PROTEASE INHIBITOR RO 31-8959 AND ZIDOVUDINE, 2',3'-DIDEOXYCYTIDINE, OR RECOMBINANT INTERFERON-ALPHA-A AGAINST ZIDOVUDINE-SENSITIVE OR ZIDOVUDINE-RESISTANT HIV-1 INVITRO
    JOHNSON, VA
    MERRILL, DP
    CHOU, TC
    HIRSCH, MS
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05): : 1143 - 1146
  • [17] A fossil record of zidovudine resistance in transmitted isolates of HIV-1
    Kuritzkes, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13485 - 13487
  • [18] SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS OF ZIDOVUDINE-RESISTANT ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS
    RICHMAN, DD
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (5B): : S8 - S10
  • [19] Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient
    de Ronde, A
    van Dooren, M
    de Rooij, E
    van Gemen, B
    Lange, J
    Goudsmit, J
    AIDS, 2000, 14 (16) : 2632 - 2633
  • [20] Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro
    Harrigan, PR
    Bloor, S
    Larder, BA
    JOURNAL OF VIROLOGY, 1998, 72 (05) : 3773 - 3778
12345